$13.12
2.81%
NYSE, Jul 11, 10:10 pm CET
ISIN
US58502B1061
Symbol
MD

MEDNAX, Inc. Stock price

$13.12
-1.10 7.74% 1M
-0.19 1.43% 6M
+0.00 0.00% YTD
+5.91 81.97% 1Y
-9.54 42.10% 3Y
-5.20 28.38% 5Y
-63.50 82.88% 10Y
-5.91 31.04% 20Y
NYSE, Closing price Fri, Jul 11 2025
-0.38 2.81%
ISIN
US58502B1061
Symbol
MD
Sector

Key metrics

Basic
Market capitalization
$1.1b
Enterprise Value
$1.5b
Net debt
$393.4m
Cash
$219.2m
Shares outstanding
85.8m
Valuation (TTM | estimate)
P/E
negative | 7.7
P/S
0.6 | 0.6
EV/Sales
0.8 | 0.8
EV/FCF
7.8
P/B
1.4
Financial Health
Equity Ratio
35.5%
Return on Equity
-13.0%
ROCE
11.5%
ROIC
11.9%
Debt/Equity
0.8
Financials (TTM | estimate)
Revenue
$2.0b | $1.9b
EBITDA
$225.3m | $238.9m
EBIT
$198.0m | $209.1m
Net Income
$-82.4m | $147.2m
Free Cash Flow
$194.3m
Growth (TTM | estimate)
Revenue
-1.1% | -4.1%
EBITDA
18.7% | 10.6%
EBIT
30.1% | 13.8%
Net Income
-16.7% | 248.5%
Free Cash Flow
138.9%
Margin (TTM | estimate)
Gross
-
EBITDA
11.4% | 12.4%
EBIT
10.0%
Net
-4.2% | 7.6%
Free Cash Flow
9.8%
More
EPS
$-1.0
FCF per Share
$2.3
Short interest
3.6%
Employees
4k
Rev per Employee
$490.0k
Show more

Is MEDNAX, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

MEDNAX, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a MEDNAX, Inc. forecast:

10x Buy
63%
6x Hold
38%

Analyst Opinions

16 Analysts have issued a MEDNAX, Inc. forecast:

Buy
63%
Hold
38%

Financial data from MEDNAX, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,976 1,976
1% 1%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 1,646 1,646
2% 2%
83%
- Research and Development Expense - -
-
-
225 225
19% 19%
11%
- Depreciation and Amortization 27 27
27% 27%
1%
EBIT (Operating Income) EBIT 198 198
30% 30%
10%
Net Profit -82 -82
17% 17%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about MEDNAX, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MEDNAX, Inc. Stock News

Neutral
Business Wire
13 days ago
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Board Appoints Kurt D. Newman, M.D. as Independent Director.
Neutral
Seeking Alpha
2 months ago
Pediatrix Medical Group, Inc. (NYSE:MD ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Mark Ordan - Chief Executive Officer Kasandra Rossi - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Philip Chickering - Deutsche Bank Jack Levin - Jefferies Operator [Abruptly Started] Certain statements and information during this conference call may be d...
Neutral
Business Wire
2 months ago
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports First Quarter Results.
More MEDNAX, Inc. News

Company Profile

MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company's solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting. MEDNAX was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

Head office United States
CEO Mark Ordan
Employees 4,120
Founded 1979
Website www.pediatrix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today